The Conventional Medical Arsenal for Treating Influenza

presented by

Silver Bullet Enterprises

Producers of Safe, Simple and Economical

Colloidal Silver Generators

and related Products... 

111 W.S. 1st Street, #110

Johnstown, Colorado 80534






We are retailers of Colloidal Silver Generation Equipment. We believe that the information we provide and the equipment we sell can help you to improve the quality of life for yourself and your family . That is our goal.


The Conventional Medical Arsenal for Treating Influenza

Conventional medical authorities battle potential "flu" epidemics using vaccination as their primary weapon. This method of Flu treatment is approved by the FDA.

The vaccination "weapon", is at best, a double edged sword.

The apparent benefit is a reduced risk of catching Influenza.

This benefit may be defeated if the strain against which the vaccine is effective is not the predominant strain affecting the general population in any given flu season. ( If you were vaccinated against type A but type B is the one you are exposed to, you may get the flu anyway. This is a "not uncommon" occurrence.)

The "downside" of flu vaccination, for many people appears to outweigh the potential benefit.

Link to a list of "Peer Reviewed Citations of flu vaccine damage"

To say the least, the injection of a complex biological compound, containing Thimerosal…a form of Mercury…as a preservative may not be in the best interest of the patient. (The Thimerosol Controversy)

Quoting information from:

"In June 1999, the Food and Drug Administration discovered that "Infants who receive thimerosal containing vaccine at several visits may be exposed to more mercury than recommended by Federal guidelines for total mercury exposure." Thimerosal, a preservative used in some vaccines to prevent contamination, is 49.6% mercury by weight. Infants who are being vaccinated using multi-dose vials with thimerosal can receive 62.5 micrograms of mercury per visit. For an average sized child this represents an exposure approximately 100 times the 0.1 micrograms per kilogram of daily exposure considered safe by the Environmental Protection Agency. The manufactures safety data sheet for thimerosal states, "Highly toxic…Danger of cumulative effects…Avoid prolonged or repeated exposure… and the Chemical, physical, and toxicological properties have not been thoroughly investigated.""

In general the risks inherent with Flu vaccination include:

Soreness at the injection site

Muscle aches & pains



Increased risk of /exacerbation of problems caused by Mercury exposure / toxcicity  (Iowa, among other states, has banned the injection of infants & pregnant women with compounds containing more than trace amounts of mercury...specifically to prevent such complications.)

Alzheimer’s Disesase ... Increased Risk
Hugh Fudenberg, MD, an immunogeneticist and biologist, Founder and Director of Research, Neurolmmuno Therapeutic Research Foundation, with numerous papers published in peer review journals, has reported that if an individual had five consecutive flu shots between 1970 and 1980 (the years studied), his/her chances of getting Alzheimer's Disease is ten times higher than if they had zero, one, or two shots.  Information comes from  Dr. Fudenberg's speech at the NVIC International Vaccine Conference, Arlington, VA September, 1997.

Dr. Boyd Haley, Professor and Chair of the Department of Chemistry at the University of Kentucky, Lexington has done extensive research in the area of mercury toxicity and the brain. His research has established a likely connection between mercury toxicity and Alzheimer’s disease.  (The Relationship of Toxic Effects of Mercury to Exacerbation of the Medical Condition Classified as Alzheimer’s Disease by Boyd E. Haley, PhD.)

In a paper published in collaboration with researchers at University of Calgary, Haley stated that “seven of the characteristic markers that we look for to distinguish Alzheimer's disease can be produced in normal brain tissues, or cultures of neurons, by the addition of extremely low levels of mercury.” (NeuroReport, 12(4):733-737, 2001)

Does the above information establish, beyond a doubt, a "cause and effect" relationship between mercury toxicity and alzheimer's? No, certainly not.

It does establish a reasonable basis for the average person to exhibit extreme caution in the decision making process related to any mercury containing product that might be ingested or injected.

Autism in children. (Autism defined) (Autism RNA Therapy)

Every year in the United States flu vaccine is in some degree of short supply, with a "dosage shortfall" projected by both news agencies and medical authorities. Blame is spread around to just about every available culprit. One year  the problem was even attributed to action or inaction by the President of the United States. (Blaming the President for this one, in my opinion is just dumb.)

Commercial anti-virals are also available, by prescription.

As a general rule,  these drugs are not readily available,  expensive, and some debate their efficacy. They have received FDA approvals.

Studies have shown that all four drugs can reduce the duration of flu symptoms by 1 day if taken within 2 days of the onset of the illness. There is no information about how effective these drugs are if treatment is started more than 2 days after onset of flu symptoms.

The four available medicines include: (as listed by

"Tamiflu (oseltamivir) helps adults 18 years and older and Relenza (zanamivir) helps adults and children 7 years and older who have an uncomplicated flu infection and who have had symptoms for no more than two days. FDA also has approved Tamiflu for use in children 1 year of age and older who have had symptoms for no more than 2 days. Both treat influenza type A and type B infections.

Flumadine (rimantadine) helps adults who have influenza type A virus infections. It has no effect on influenza type B virus infections.

Symmetrel (amantadine) may be taken by adults and children who are 1 year of age and older to prevent and treat type A influenza virus infections. Amantadine, however, is more likely to cause side effects such as lightheadedness and inability to sleep more often than is rimantadine.

Relenza (Zanamivir) Adults and pediatric patients at least 7 years of age who have influenza symptoms that appeared within the previous day or two. Typical symptoms of influenza include sudden onset of fever, cough, headache, muscular weakness, and sore throat.

To work well, you must take these medicines within 48 hours after the flu begins. "

The Flu... Historical Significance ... (previous page)

The Flu ... Prevention & Treatments that Work (next page)

The Flu ... General Information & Symptoms

Pnuemonia a Killer Disease Related to the Flu

The New USP II ...

World's most versatile Home Colloidal Silver Generator


We are not licensed Medical Professionals. We endeavor to provide accurate and useful information BUT we do not guarantee the accuracy of information on this site or any site to which we have linked. We specifically deny all liability for the use of any information on this site. We strongly recommend consultation with licensed professionals prior to beginning, ending or changing the course of treatment for any medical condition.

Citations of flu vaccine damage

Ayvazian LF.    Influenza immunization and lupus erythematosus. Ann Intern Med. 1979 Jan;90(1):127-8. No abstract available.PMID: 420449; UI: 79122584.
Antony SJ, et al.    Postvaccinial (influenza) disseminated encephalopathy (Brown-Sequard syndrome). J Natl Med Assoc. 1995 Sep;87(9):705-8. Review. PMID: 9583968; UI: 98242646.
Ashton R.  Side effects of influenza vaccination. Br J Gen Pract. 1992 Feb;42(355):82-4. No abstract available.PMID: 1493021; UI: 93152242.      
Barbuta R, et al. [Some complications of anti-influenza vaccination in a closed community of infants]. Microbiol Parazitol Epidemiol (Bucur). 1973 Sep-Oct;18(5):431-5. Romanian. No abstract available.PMID: 4767728; UI: 74068682     
Buchner H, et al.   [Polyneuritis cranialis? Brain stem encephalitis and myelitis following preventive influenza vaccination]. Nervenarzt. 1988 Nov;59(11):679-82. German. No abstract available.PMID: 3211251; UI: 89097428   
Boutros N, et al.     Delirium following influenza vaccination. Am J Psychiatry. 1993 Dec;150(12):1899. No abstract available.
PMID: 8238653; UI: 94057127.     
Bienfang DC, et al.    Ocular abnormalities after influenza immunization. Arch Ophthalmol. 1977 Sep;95(9):1649. No abstract available.PMID: 561590; UI: 77266169.
Biasi D, et al.   A case of reactive arthritis after influenza vaccination. Clin Rheumatol. 1994 Dec;13(4):645. No abstract available.PMID: 7697972; UI: 95212114.
Bodokh I, et al.    [Reactivation of bullous pemphigoid after influenza vaccination]. Therapie. 1994 Mar-Apr;49(2):154. French. No abstract available.PMID: 7817351; UI: 95117082.
Beijer WE, et al.     [Polymyalgia rheumatica and influenza vaccination]. Dtsch Med Wochenschr. 1993 Feb 5;118(5):164-5. German. No abstract available.PMID: 8432239; UI: 93161913.
Beghi E, et al.     Guillain-Barre syndrome. Clinicoepidemiologic features and effect of influenza vaccine. Arch Neurol. 1985 Nov;42(11):1053-7. PMID: 4051833; UI: 86024965.
Bernad Valles M, et al.     [Adverse reactions to different types of influenza vaccines]. Med Clin (Barc). 1996 Jan 13;106(1):11-4. Spanish. PMID: 8750535; UI: 96286238. 
Bierman CW, et al. Safety of influenza vaccination in allergic children. J Infect Dis. 1977 Dec;136 Suppl:S652-5. PMID: 564376; UI: 78110305.[See Related Articles]

Breman JG, et al. Guillain-Barre syndrome and its relationship to swine influenza vaccination in Michigan, 1976-1977. Am J Epidemiol. 1984 Jun;119(6):880-9.   PMID: 6731430; UI: 84228448.

Brown RC, et al.    Thrombotic thrombocytopenic purpura after influenza vaccination. Br Med J. 1973 May 5;2(861):303. No abstract available.PMID: 4735793; UI: 73177095.      
Brown MA, et al.     Rheumatic complications of influenza vaccination. Aust N Z J Med. 1994 Oct;24(5):572-3. No abstract available.PMID: 7848162; UI: 95150894.
Blanche P, et al.   Development of uveitis following vaccination for influenza. Clin Infect Dis. 1994 Nov;19(5):979. No abstract available.PMID: 7893899; UI: 95201116.
Blumberg S, et al.     A possible association between influenza vaccination and small-vessel vasculitis. Arch Intern Med. 1980 Jun;140(6):847-8. PMID: 7387284; UI: 80219228.
Cambiaghi S, et al. Gianotti-Crosti syndrome in an adult after influenza virus vaccination. Dermatology. 1995;191(4):340-1. No abstract available.PMID: 8573937; UI: 96159483
Cummins D, Wilson ME, Foulger KJ, Dawson D, Hogarth AM.  Haematological changes associated with influenza vaccination in people aged over 65: case report and prospective study. Clin Lab Haematol. 1998 Oct;20(5):285-7.PMID: 9807675 [PubMed - indexed for MEDLINE]
Blood count abnormalities are a recognized feature of many viral infections and immunizations but little is known about the haematological effects of influenza vaccination. We report a 67-year-old patient who developed thrombocytopenia and severe neutropenia 3 weeks after she was vaccinated against influenza. The case led us to study prospectively the blood counts of 70 people aged over 65 before and after they received influenza vaccine. There were no significant changes in the levels of haemoglobin, neutrophils, monocytes, eosinophils or platelets after vaccination, but the total WBC counts (mean +/- SD, 6.86 +/- 1.52) and lymphocyte counts (1.69 +/- 0.61) were significantly lower at 4 weeks than at baseline (7.22 +/- 1.60 [P = 0.02] and 1.86 +/- 0.62 [P = 0.001] respectively) and in four subjects the lymphocyte count fell to below 0.7 x 10(9)/l. Since influenza vaccine does not contain live virus, its haematological effects presumably relate to the host immune response rather than to viral replication.
Confino I, et al.     Erythromelalgia following influenza vaccine in a child. Clin Exp Rheumatol. 1997 Jan-Feb;15(1):111-3. PMID: 9093785; UI: 97247658.
Casoli P, et al.    [Acute idiopathic thrombocytopenic purpura after anti-influenza vaccination]. Medicina (Firenze). 1989 Oct-Dec;9(4):417-8. Italian. PMID: 2634230; UI: 90231074.
Cannata J, et al.    Reactivation of vasculitis after influenza vaccination. Br Med J (Clin Res Ed). 1981 Aug 22;283(6290):526. No abstract available.PMID: 6790053; UI: 81257661   
Downs AM, et al.     Does influenza vaccination induce bullous pemphigoid? A report of four cases. Br J Dermatol. 1998 Feb;138(2):363. No abstract available.PMID: 9602897; UI: 98265607.
Desson JF, et al.     [Acute benign pericarditis after anti-influenza vaccination]. Presse Med. 1997 Mar 22;26(9):415. French. No abstract available.PMID: 9137397; UI: 97283264.
Dyro FM.    Vaccination mononeuropathy. Ann Neurol. 1978 May;3(5):468. No abstract available.PMID: 215078; UI: 79081241.  

Ehrengut W.     [Side effects of influenza vaccinations]. Dtsch Med Wochenschr. 1979 Dec 28;104(52):1836. German. No abstract available.PMID: 520180; UI: 80091277.

Ehrengut W, et al. [Neurological complications after influenza vaccination]. MMW Munch Med Wochenschr. 1977 May 20;119(20):705-10. German. PMID: 406554; UI: 77212853.

Fournier B, et al.    Bullous pemphigoid induced by vaccination. Br J Dermatol. 1996 Jul;135(1):153-4. No abstract available.PMID: 8776390; UI: 96372575.    
Furlow TW Jr.  Neuropathy after influenza vaccination [letter]. Lancet. 1977 Jan 29;1(8005):253-4. No abstract available.PMID: 64777; UI: 77099010.
Fiser Dj, et al.       [Anosmia after administration of influenza vaccine]. Med Pregl. 1979;32(9-10):455-7. Serbo-Croatian (Cyrillic). No abstract available.PMID: 530224; UI: 80120256.
Felix JK, et al.     Isolated hypoglossal nerve paralysis following influenza vaccination. Am J Dis Child. 1976 Jan;130(1):82-3.
PMID: 174422; UI: 76109122.     
Froissart M, et al.    [Acute meningoencephalitis immediately after an influenza vaccination]. Lille Med. 1978 Oct;23(8):548-51. French. No abstract available.PMID: 723420; UI: 79072015   
Graus F, et al.     Acute necrotic myelopathy associated with influenza vaccination. Lancet. 1987 Jun 6;1(8545):1311-2. No abstract available.PMID: 2884426; UI: 87227723.
Gross WL, et al.  Meningoencephalitis syndrome following influenza vaccination. J Neurol. 1978 Feb 14;217(3):219-22. PMID: 75958; UI: 78132024.
Guillevin L, et al.   [Hypersensitivity reaction following vaccination against influenza]. Presse Med. 1983 Jun 18;12(26):1668-9. French. No abstract available.PMID: 6224154; UI: 83273366.        

Gerth HJ. [Polymyalgia rheumatica and influenza vaccination]Dtsch Med Wochenschr. 1992 Aug 14;117(33):1259-60. German. No abstract available.PMID: 1499526 [PubMed - indexed for MEDLINE]

Gerth HJ.     [Letter: Influenza following influenza vaccination]. Dtsch Med Wochenschr. 1976 Jul 2;101(27):1043. German. No abstract available.PMID: 1278041; UI: 76209788.
Goodman RA, et al.    Influenza and influenza vaccination. Am Fam Physician. 1980 Jan;21(1):101-5. PMID: 7350730; UI: 80085069.     
Gurtovoi MI.   [Discovery of a possible connection between vaccination with inactivated chromatographic influenza vaccine and the development of the Guillain-Barre syndrome]. Tr Inst Im Pastera. 1985;63:78-81. Russian. No abstract available.PMID: 3843161; UI: 87179166.
Hjorth RN, et al. Experimental neuritis induced by a mixture of neural antigens and influenza vaccines. A possible model for Guillain-Barre syndrome. J Neuroimmunol. 1984 Feb;6(1):1-8. PMID: 6707195; UI: 84162569.
Houston TP.    Small-vessel vasculitis following simultaneous influenza and pneumococcal vaccination. N Y State J Med. 1983 Oct-Nov;83(11-12):1182-3. No abstract available.PMID: 6580565; UI: 84068900.
Herderschee D, et al. [Myelopathy following influenza vaccination]. Ned Tijdschr Geneeskd. 1995 Oct 21;139(42):2152-4. Dutch. PMID: 7477581; UI: 96054742
Hannoun C.      [Problems of influenza vaccination]. Rev Med Suisse Romande. 1974 Apr;94(4):319-23. French. No abstract available.PMID: 4826392; UI: 74157136.
Heidel G, et al.     [Neurologic syndromes as atypical courses of vaccination following preventive influenza A vaccination]. Z Gesamte Hyg. 1985 Apr;31(4):218-20. German. No abstract available.PMID: 4013430; UI: 85246763.

Hasselbacher P.   Neuropathy after influenza vaccination [letter]. Lancet. 1977 Mar 5;1(8010):551-2. No abstract available.PMID: 65654; UI: 77122811.       

Hull TP, et al.     Optic neuritis after influenza vaccination. Am J Ophthalmol. 1997 Nov;124(5):703-4. PMID: 9372734; UI: 98040003.

Honkanen PO, et al.   Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly. Arch Intern Med. 1996 Jan 22;156(2):205-8. PMID: 8546555; UI: 96136003.

Ichikawa N, et al. [Recurrent aseptic meningitis following influenza vaccination in a case of systemic lupus erythematosus]. Rinsho Shinkeigaku. 1983 Jul;23(7):570-6. Japanese. No abstract available.PMID: 6661861; UI: 84107365.
Jovanovic D.     Respiratory effects of live influenza virus vaccine. Am Rev Respir Dis. 1977 Dec;116(6):1121. No abstract available.PMID: 931188; UI: 78058888     
Kawasaki A, et al.    Bilateral anterior ischemic optic neuropathy following influenza vaccination. J Neuroophthalmol. 1998 Mar;18(1):56-9. PMID: 9532544; UI: 98193723.
Kumbar UN, et al.    Urticarial rash, periorbital edema following influenza (bivalent) vaccination [letter]. Can Med Assoc J. 1977 Apr 9;116(7):724. No abstract available.PMID: 849552; UI: 77136163.
Kramer P, et al.    Depression of aminopyrine metabolism by influenza vaccination. N Engl J Med. 1981 Nov 19;305(21):1262-4. No abstract available.PMID: 7290142; UI: 82035768.
Kelsall JT, et al.    Microscopic polyangiitis after influenza vaccination. J Rheumatol. 1997 Jun;24(6):1198-202. Review. PMID: 9195534; UI: 97338974  

Keenlyside RA, et al. Fatal Guillain-Barre syndrome after the national influenza immunization program. Neurology. 1980 Sep;30(9):929-33. PMID: 6252515; UI: 81031247.
Fifty-eight fatal cases of Guillain-Barre syndrome (GBS) were reported during the 1976 to 1977 National Influenza Program: Thirty-two (58%) of these patients had received the A/New Jersey influenza vaccine. The mean interval from vaccination to onset was 3.9 weeks, and the incidence of preceding illness in vaccinated or unvaccinated patients was similar. Fifty-eight percent had at least one chronic disease before onset. The clinical features were similar in vaccinated and unvaccinated patients. Most deaths followed medical complications of respiratory paralysis: Fifteen had pneumonia, 29 (83%) died suddenly, 15 had sudden arrhythmias or hypotension, and 7 had myocardial infarction or pulmonary embolus.   

Liozon E, Ittig R, Vogt N, Michel JP, Gold G.  Polymyalgia rheumatica following influenza vaccination.J Am Geriatr Soc. 2000 Nov;48(11):1533-4. No abstract available.PMID: 11083341 [PubMed - indexed for MEDLINE]

Lohse A, et al.    Vascular purpura and cryoglobulinemia after influenza vaccination. Case-report and literature review. Rev Rhum Engl Ed. 1999 Jun;66(6):359-60. No abstract available.PMID: 10418068; UI: 99346622.

Lear JT, et al. Bullous pemphigoid following influenza vaccination. Clin Exp Dermatol. 1996 Sep;21(5):392. No abstract available.PMID: 9136169; UI: 97281896.

Lasky T, et al.      The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med. 1998 Dec 17;339(25):1797-802. PMID: 9854114; UI: 99061022.

Macoul KL. Bilateral optic nerve atrophy and blindness following swine influenza vaccination. Ann Ophthalmol. 1982 Apr;14(4):398-9. No abstract available.PMID: 7103325; UI: 82255038.
Mantel N.     Re: "An epidemiologic and clinical evaluation of Guillain-Barre syndrome reported in association with the administration of swine influenza vaccines". Am J Epidemiol. 1985 Apr;121(4):620-3. No abstract available.PMID: 4014151; UI: 85248370.
Patel U, et al.     Henoch-Schonlein purpura after influenza vaccination. Br Med J (Clin Res Ed). 1988 Jun 25;296(6639):1800. No abstract available.PMID: 3136851; UI: 88310148.
Park CL, et al.   Does influenza vaccination exacerbate asthma? Drug Saf. 1998 Aug;19(2):83-8. Review. PMID: 9704246; UI: 98369869.
Perry HD, et al. Reversible blindness in optic neuritis associated with influenza vaccination. Ann Ophthalmol. 1979 Apr;11(4):545-50. PMID: 453752; UI: 79207772.

A patient is reported in whom bilateral optic neuritis developed following an influenza vaccination. From complete blindness (absence of light perception) in one eye, the patient's vision returned to normal following steroid treatment.

Perez C, Maravi E.  Polymyalgia rheumatica following influenza vaccination.Muscle Nerve. 2000 May;23(5):824-5. No abstract available.PMID: 10797410 [PubMed - indexed for MEDLINE]

Pelosio A, et al.     [Influenza vaccination and polyradiculoneuritis of the Guillain-Barre type]. Medicina (Firenze). 1990 Apr-Jun;10(2):169. Italian. PMID: 2273957; UI: 91109533.

Poser C .  Neurological complications of swine influenza vaccination.   Acta Neurol Scand 1982 Oct;66(4):413-31
The emphasis upon the remarkably large number of cases of Guillain-Barre syndrome which resulted from the 1976 National Swine Influenza immunization program in the U.S.A. has obscured the fact that other neurological complications, involving the central nervous system also occurred. The anatomical distribution of lesions is almost identical with that seen following other types of vaccination: involvement of the brain, cerebellum, optic nerve, cranial nerves and spinal cord occurred with approximately the same frequency. 5 instances of the very rare subacute or chronic, progressive, post-vaccinal encephalopathy are described, a situation which is identical to the subacute and chronic forms of polyradiculoneuropathy. In a number of cases, in particular the myelopathies, a subclinical involvement of peripheral nerves was demonstrated by means of electrodiagnostic studies, illustrating the often overlooked fact that central nervous system involvement will mask peripheral nerve lesions. The etiological significance of the swine influenza vaccination was overlooked and completely erroneous diagnoses were established in a surprisingly large number of the 26 new cases reported here.  PMID: 6128862, UI: 83070654 

Langmuir AD, et al.  An epidemiologic and clinical evaluation of Guillain-Barre syndrome reported in association with the administration of swine influenza vaccines.  Am J Epidemiol. 1984 Jun;119(6):841-79. PMID: 6328974; UI: 84228447.
As a result of a court order, computerized summaries of approximately 1,300 cases reported as Guillain-Barre syndrome by state health departments to the Centers for Disease Control during the intensive national surveillance instituted following the swine influenza vaccination program in 1976-1977 became available for further study. Although the data were not uniformly adequate to confirm the diagnosis of Guillain-Barre syndrome, they were sufficient to enable classification according to extent of motor involvement. Vaccinated cases with "extensive" paresis or paralysis occurred in a characteristic epidemiologic pattern closely approximated by a lognormal curve, suggesting a causal relationship between the disease and the vaccine. Cases with "limited" motor involvement showed no such pattern, suggesting that this group included a substantial proportion of cases which were unrelated to the vaccine. The effect attributed to the vaccine lasted for at least six weeks and possibly for eight weeks but not longer. The relative risk of acquiring "extensive" disease over a six-week period following vaccination ranged from 3.96 to 7.75 depending on the particular baseline estimate of expected normal or endemic incidence that was chosen. Correspondingly, the number of cases that could be attributed to the vaccine over the six-week period ranged from 211 to 246, or very slightly higher over an eight-week period if the lowest baseline estimate was used. The total rate of Guillain-Barre syndrome cases attributed to prior use of the vaccine was 4.9 to 5.9 per million vaccinees.

Lasky T, et al. The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med. 1998 Dec 17;339(25):1797-802. PMID: 9854114; UI: 99061022.
Molina M, et al.   [Leukocytoclastic vasculitis secondary to flu vaccination]. Med Clin (Barc). 1990 Jun 9;95(2):78. Spanish. No abstract available.PMID: 2250511; UI: 91066593.

Mader R, et al. Systemic vasculitis following influenza vaccination--report of 3 cases and literature review. J Rheumatol. 1993 Aug;20(8):1429-31. Review. PMID: 8230034; UI: 94046875.
Influenza vaccination is a widely accepted practice particularly among the elderly and high risk individuals. Minor and transitory
side effects following the vaccination are common while systemic complications are infrequently reported. We describe 3 patients who developed systemic vasculitis following influenza vaccination. With increasing use of influenza vaccination, attention should be drawn to the possible expression of systemic adverse effects such as vasculitis.

Milkowski S.   [Ocular complications following influenza]. Wiad Lek. 1971 Jan 15;24(2):103-8. Polish. No abstract available.PMID: 5100901; UI: 71109124.

 [Vaccination and the Guillan-Barre syndrome]. Ned Tijdschr Geneeskd. 1978 Nov 11;122(45):1780. Dutch. No abstract available.PMID: 703884; UI: 79032243.

Nakashima K, et al. [Two cases of acute polyradiculoneuritis associated with influenza A virus infection and vaccination]. Rinsho Shinkeigaku. 1982 Mar;22(3):223-8. Japanese. No abstract available.PMID: 7105595; UI: 82260254.

Nicholson, Karl G.; Nguyen-Van-Tam, Jonathan S.; Ahmed, Ala'eldin H.; et al. "Randomized Placebo-Controlled Crossover Trial on Effect of Inactivated Influenza Vaccine on Pulmonary Function in Asthma" Lancet (01/31/98) Vol. 351, No. 9099, P. 326;

British researchers report that there is a correlation between pulmonary-function abnormalities and complications due to flu vaccination, although the risk is quite small and the benefits of vaccination outweigh the complications that may occur. The team studied 262 adults in a double-blind, placebo-controlled crossover study of 262 adults to evaluate the safety of flu vaccination in asthma patients. Despite current guidelines, asthma patients often do not receive annual flu shots, in part, due to concerns that the vaccine will trigger exacerbations. For two weeks before the first injection until two weeks after the second injection, the subjects kept a record of daily peak expiratory flow (PEF), respiratory symptoms, medication, medical consultations, and hospital admissions. Of the 255 patients with paired data, 11 saw a reduction in PEF greater than 20 percent, while eight had a decline in PEF of more 30 percent. Only three of the placebo receiving subjects had PEF reduction greater than 20 percent, and none had a reduction greater than 30 percent. When the researchers excluded subjects with colds--which can trigger exacerbations and may be mistaken for vaccine-related adverse events--there was no significant difference in PEF decline, although they said the difference for PEF declines of more than 30 percent approached significance.

Owensby JE, et al.  Cellulitis and myositis caused by Agrobacterium radiobacter and Haemophilus parainfluenzae after influenza virus vaccination. South Med J. 1997 Jul;90(7):752-4. PMID: 9225903; UI: 97369415.
Pelosio A, et al. [Influenza vaccination and polyradiculoneuritis of the Guillain-Barre type]. Medicina (Firenze). 1990 Apr-Jun;10(2):169. Italian. PMID: 2273957; UI: 91109533
Ramakrishnan N, et al.  Thrombotic thrombocytopenic purpura following influenza vaccination--a brief case report. Conn Med. 1998 Oct;62(10):587-8. No abstract available.PMID: 9821723; UI: 99039164.
Ray CL, et al.    Bilateral optic neuropathy associated with influenza vaccination. J Neuroophthalmol. 1996 Sep;16(3):182-4. PMID: 8865010; UI: 97018394      
Rieger HJ.      [Compensation claims in lesions caused by influenza vaccinations at work]. Dtsch Med Wochenschr. 1976 Apr 23;101(17):677-8. German. No abstract available.PMID: 1261394; UI: 76164840    
Robinson T, et al.     Side effects of influenza vaccination. Br J Gen Pract. 1992 Nov;42(364):489-90. No abstract available.PMID: 1472400; UI: 93112469.  
Rosenberg GA.   Meningoencephalitis following an influenza vaccination. N Engl J Med. 1970 Nov 26;283(22):1209. No abstract available.PMID: 4394376; UI: 71012572.
Roscelli JD, et al.   Guillain-Barre syndrome and influenza vaccination in the US Army, 1980-1988. Am J Epidemiol. 1991 May 1;133(9):952-5. PMID: 2028981; UI: 91229076.

Retailliau HF, et al.  Illness after influenza vaccination reported through a nationwide surveillance system, 1976-1977.  Am J Epidemiol. 1980 Mar;111(3):270-8. PMID: 7361749; UI: 80150827.

Selvaraj N, et al.    Hemiparesis following influenza vaccination. Postgrad Med J. 1998 Oct;74(876):633-5. No abstract available.PMID: 10211371; UI: 99227817
Saito H, et al.     Acute disseminated encephalomyelitis after influenza vaccination. Arch Neurol. 1980 Sep;37(9):564-6. PMID: 7417057; UI: 81020711.     

Saito H, et al.   Acute cerebellar ataxia after influenza vaccination with recurrence and marked cerebellar atrophy. Tohoku J Exp Med. 1989 May;158(1):95-103. PMID: 2781544; UI: 89388779.

Sawada Y, et al.     [Case of skin ulcer due to influenza HA vaccination]. Nippon Hifuka Gakkai Zasshi. 1983 Nov;93(12):1297-301. Japanese. No abstract available.PMID: 6676495; UI: 84216828.

Schmutz JL, et al.   [Does influenza vaccination induce bullous pemphigoid]? Ann Dermatol Venereol. 1999 Oct;126(10):765. French. No abstract available.PMID: 10604026; UI: 20071693.

Scholl R, et al.     [Neurologic disorders following influenza vaccination. A case report]. Med Welt. 1978 Nov 3;29(44):1707-9. German. No abstract available.PMID: 713791; UI: 79052411.
Streifler JJ, et al.    Recurrent pericarditis: a rare complication of influenza vaccination. Br Med J (Clin Res Ed). 1981 Aug 22;283(6290):526-7. No abstract available.PMID: 6790054; UI: 81257662    

Schonberger LB, et al.    Guillain-Barre syndrome: its epidemiology and associations with influenza vaccination. Ann Neurol. 1981;9 Suppl:31-8. PMID: 7224614; UI: 81182844.

(Schevill S; Can Med Assoc J, 1977 Feb 5) Adverse reactions to 1975 bivalent influenza vaccine in children.

Schonberger LB, et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977.  Am J Epidemiol. 1979 Aug;110(2):105-23. PMID: 463869; UI: 79228981.

Solomon A, et al.     Bilateral simultaneous corneal graft rejection after influenza vaccination. Am J Ophthalmol. 1996 Jun;121(6):708-9. PMID: 8644815; UI: 96243666.
Strom J.     Cytological changes in the urine in the form of inclusion-bearing cells, giant cells and haematuria after vaccination with inactivated influenza virus vaccine. A study with application of Millipore procedure and Papanicolaou staining. Scand J Infect Dis. 1976;8(1):21-5. PMID: 57642; UI: 76177972.
Stohr M, et al.   [Neurologic diseases following influenza vaccination]. Med Welt. 1976 May 7;27(19):912-4. German. No abstract available.PMID: 1272054; UI: 76195488.   
Winkelmann RK.     Influenza vaccine and dermatomyositis. Lancet. 1982 Aug 28;2(8296):495. No abstract available.PMID: 6125660; UI: 82270838.
Wharton CF, et al.    Letter: Polyarteritis after influenza vaccination. Br Med J. 1974 May 11;2(914):331-2. No abstract available.PMID: 4151218; UI: 74160231.
Wattiaux MJ, et al.   [Rheumatoid purpura following influenza vaccination]. Presse Med. 1988 Apr 9;17(13):649-50. French. No abstract available.PMID: 2966945; UI: 88217802.
Ward DL.   Re: "Guillain-Barre syndrome and influenza vaccination in the US Army, 1980-1988". Am J Epidemiol. 1992 Aug 1;136(3):374-6. No abstract available.PMID: 1415156; UI: 93035252.
Young G.     Side effects of influenza immunization. Br J Gen Pract. 1992 Mar;42(356):131. No abstract available.PMID: 1303654; UI: 93152256.
Yahr MD, et al.     Relapsing encephalomyelitis following the use of influenza vaccine. Arch Neurol. 1972 Aug;27(2):182-3. No abstract available.PMID: 5040635; UI: 72226875.

The Flu... Historical Significance ... (previous page)

The Flu ... Prevention & Treatments that Work (next page)

The Flu ... General Information & Symptoms


The New USP II ...

World's most versatile Home Colloidal Silver Generator


We Accept    And    PayPal  

When you use your credit card to pay for  merchandise on our site, the transaction is processed by  PayPal

 Silver Bullet Enterprises employees never have access to your private financial data.

 PayPal employs full time professional security experts, who's only job is to protect the integrity of credit card data.

We have chosen  PayPal as our payment processor so that we can be sure your transactions are secure and that your money and data will remain safe



            USP II Generator (our best)    USP Generator    Other Products    Conventional Generators               Order Form       Literature    Merchandise Disclaimer    Home